Global GMP Grade Fetal Bovine Serum Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global GMP Grade Fetal Bovine Serum Market Research Report 2024
Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin and clotting factors, but containing a large number of nutritional and macromolecular factors essential for cell growth. Bovine serum albumin is the major component of FBS
According to Mr Accuracy reports new survey, global GMP Grade Fetal Bovine Serum market is projected to reach US$ 868 million in 2029, increasing from US$ 675 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole GMP Grade Fetal Bovine Serum market research.
The animal serum product market is primarily driven by its extensive use in various applications, including cell culture, biopharmaceutical production, and diagnostics. Fetal bovine serum (FBS) and other animal-derived sera contain essential nutrients and growth factors necessary for cell growth and viability, making them indispensable in research and industrial processes. Moreover, the increasing demand for biologics and personalized medicine fuels the need for high-quality animal serum products to support cell-based therapies and recombinant protein production. However, the market also faces challenges, notably concerns about ethical considerations and the risk of contaminations associated with animal-derived products. There is a growing push towards animal-free and defined media alternatives to address these challenges. Additionally, the variability in serum composition from different sources and batches poses a challenge in ensuring consistent and reproducible results in cell-based research and biomanufacturing.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global GMP Grade Fetal Bovine Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher
Cytiva
Merck
Moregate BioTech
Gemini
R&D Systems
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
Segment by Type
North America-sourced
South America-sourced
Australia-sourced
Others
Vaccine Production
Biopharma Production
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The GMP Grade Fetal Bovine Serum report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global GMP Grade Fetal Bovine Serum market is projected to reach US$ 868 million in 2029, increasing from US$ 675 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole GMP Grade Fetal Bovine Serum market research.
The animal serum product market is primarily driven by its extensive use in various applications, including cell culture, biopharmaceutical production, and diagnostics. Fetal bovine serum (FBS) and other animal-derived sera contain essential nutrients and growth factors necessary for cell growth and viability, making them indispensable in research and industrial processes. Moreover, the increasing demand for biologics and personalized medicine fuels the need for high-quality animal serum products to support cell-based therapies and recombinant protein production. However, the market also faces challenges, notably concerns about ethical considerations and the risk of contaminations associated with animal-derived products. There is a growing push towards animal-free and defined media alternatives to address these challenges. Additionally, the variability in serum composition from different sources and batches poses a challenge in ensuring consistent and reproducible results in cell-based research and biomanufacturing.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global GMP Grade Fetal Bovine Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher
Cytiva
Merck
Moregate BioTech
Gemini
R&D Systems
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
Segment by Type
North America-sourced
South America-sourced
Australia-sourced
Others
Segment by Application
Vaccine Production
Biopharma Production
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The GMP Grade Fetal Bovine Serum report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices